The Medicines Company

PARSIPPANY, NJ -- (Marketwire) -- 05/08/12 -- The Medicines Company (NASDAQ: MDCO) will present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 15th in Las Vegas, NV beginning at 5pm Pacific Time. William O'Connor, Chief Accounting Officer will provide a company overview. The sessions will ... read more

PARSIPPANY, NJ -- (Marketwire) -- 04/30/12 -- The Medicines Company (NASDAQ: MDCO) will present at the Deutsche Bank 37th Annual Healthcare Conference on Monday, May 7th in Boston, MA beginning at 2:10pm Eastern Time. Clive Meanwell, Chairman and Chief Executive Officer, will provide a company overview. The sessions will ... read more

PARSIPPANY, NJ -- (Marketwire) -- 04/25/12 -- The Medicines Company (NASDAQ: MDCO), a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines, today announced first quarter financial results for 2012. Financial highlights for the first quarter of 2012: Net ... read more

PARSIPPANY, NJ -- (Marketwire) -- 04/10/12 -- The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, April 25th at 8:30 a.m. Eastern Time to discuss first quarter 2012 financial results, operational developments and outlook for 2012. The conference call will be available via phone and ... read more

PARSIPPANY, NJ -- (Marketwire) -- 03/07/12 -- The Medicines Company (NASDAQ: MDCO) will present at the 2012 Barclays Capital Global Healthcare Conference on Tuesday, March 13th, in Miami, FL beginning at 4:15pm Eastern Time. Glenn Sblendorio, President and Chief Financial Officer, will provide a company overview. The sessions will ... read more

PARSIPPANY, NJ -- (Marketwire) -- 02/22/12 -- The Medicines Company (NASDAQ: MDCO) today announced its financial results for the fourth quarter and full year of 2011. Financial highlights for the fourth quarter of 2011: Net revenue increased by 10.5% to $132.2 million for the fourth quarter of 2011 from $119.7 ... read more

PARSIPPANY, NJ -- (Marketwire) -- 02/21/12 -- The Medicines Company (NASDAQ: MDCO) will present at the 2012 Citi Global Healthcare Conference on Monday, February 27th, in New York City beginning at 9am Eastern Time. Glenn Sblendorio, Chief Financial Officer and Executive Vice President, will provide a company ... read more

PARSIPPANY, NJ -- (Marketwire) -- 02/03/12 -- The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, February 22nd at 8:30 a.m. Eastern Time to discuss fourth quarter and full year 2011 financial results, operational developments, and outlook for 2012. The conference call will be available ... read more

PARSIPPANY, NJ -- (Marketwire) -- 01/23/12 -- The Medicines Company (NASDAQ: MDCO) today announced that it has settled the lawsuits filed by MDCO in the U.S. District Court for the District of Delaware relating to the Abbreviated New Drug Application (ANDA) filed by APP Pharmaceuticals, LLC (APP) for a ... read more

PARSIPPANY, NJ -- (Marketwire) -- 01/17/12 -- The Medicines Company (NASDAQ: MDCO) today announced publication in the Journal of the American Medical Association (JAMA) of clinical trial results from testing of cangrelor, an investigational intravenous antiplatelet. The article, "Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery," is ... read more

PARSIPPANY, NJ -- (Marketwire) -- 12/22/11 -- The Medicines Company (NASDAQ: MDCO) will present at the 30th Annual J.P. Morgan Healthcare Conference on Monday, January 9th, in San Francisco, CA beginning at 3pm Pacific Time. Clive Meanwell, Chairman and Chief Executive Officer, will provide a company overview. The session ... read more

PARSIPPANY, NJ -- (Marketwire) -- 12/05/11 -- The Medicines Company (NASDAQ: MDCO) today announced a non-controlling equity investment in GeNO, LLC (GeNO), an advanced, development-stage technology company that has created unique nitric oxide (NO) generation and delivery technology. In addition to the equity stake, this investment provides MDCO ... read more

PARSIPPANY, NJ -- (Marketwire) -- 11/30/11 -- The Medicines Company (NASDAQ: MDCO) will present at the 2011 Deutsche Bank BioFEST on Monday, December 5th, in Boston beginning at 8:25am Eastern Time. Glenn Sblendorio, Chief Financial Officer and Executive Vice President, will provide a company overview. The session will ... read more

ORLANDO, FL -- (Marketwire) -- 11/14/11 -- Researchers from The Medicines Company (NASDAQ: MDCO) today presented the first data of MDCO-216 (ApoA-I Milano Complex) sourced from an improved manufacturing process. MDCO-216 is an investigational, naturally occurring variant of a protein called ApoA-I found in human high-density lipoprotein, or ... read more

ORLANDO, FL -- (Marketwire) -- 11/13/11 -- The ISAR group, world leading cardiology researchers based in Munich, Germany, today simultaneously presented and published results of the 1,721-patient randomized, double-blind, active-controlled, multicenter ISAR-REACT-4 clinical trial in patients with evidence of evolving infarction (heart attack) undergoing percutaneous coronary interventions (PCI). ... read more

SAN FRANCISCO, CA -- (Marketwire) -- 11/09/11 -- Late breaking clinical trial results from testing of cangrelor, an investigational intravenous antiplatelet, showed patients can be "bridged" from the time that their physicians stop their oral antiplatelet drugs until they undergo cardiac surgery. Study results demonstrated cangrelor maintained target ... read more

SAN FRANCISCO, CA -- (Marketwire) -- 11/08/11 -- Clinical researchers here reported the first results of a pilot study with the anticoagulant Angiomax ® (bivalirudin) as an adjunct to catheter-based procedures in patients with severely defective aortic heart valves in whom surgery was not possible. The results showed a ... read more

PARSIPPANY, NJ -- (Marketwire) -- 11/02/11 -- The Medicines Company (NASDAQ: MDCO) today announced its schedule of events at the Cardiovascular Research Foundation (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) meeting taking place from November 7-11 in San Francisco. TCT is the world's largest educational meeting specializing in interventional cardiovascular ... read more

PARSIPPANY, NJ -- (Marketwire) -- 10/26/11 -- The Medicines Company (NASDAQ: MDCO), a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines, today announced results for the third quarter of 2011. Highlights include: A 14% increase in net revenues in ... read more

PARSIPPANY, NJ -- (Marketwire) -- 10/15/11 -- Clinical investigators today reported results of the first study in open heart surgery patients of MDCO-2010, an investigational antifibrinolytic agent designed to limit blood loss during surgery. MDCO-2010 is being developed by The Medicines Company (NASDAQ: MDCO). The Phase IIa clinical trial ... read more